USPTO serial 79435434
BIAL
Reviewed by CopyMark Law Group
Status 661
- Filing date
- Status date
- Registration date
- —
- Examiner
- THOMAS, JULIE
- Law office
- TMEG LAW OFFICE 107
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with BIAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark M. Friedman
Mark M. Friedman Dr. Mark Friedman Ltd.7 Jabotinsky St.Moshe Aviv Tower, 54th floorRamat Gan, 5252007Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Non-medicated cosmetics and toiletry preparations | ACTIVE | — |
| 005 | Pharmaceutical preparations for the treatment of diseases and disorders of the central and peripheral nervous system, such as epilepsy, seizures, Parkinson's disease and Parkinson disorders, movement disorders, restless legs syndrome, dystonia, Alzheimer's disease and dementia, multiple sclerosis, stroke, migraine, neuropathic pain, diabetic neuropathies, postherpetic neuralgia, fibromyalgia, depression, bipolar disorder, schizophrenia, generalized anxiety disorder, panic disorder, social phobia, post-traumatic stress disorder, sleep disorders and attention deficit hyperactivity disorder; pharmaceutical preparations for the treatment of pain, namely, postoperative pain and back pain; pharmaceutical preparations for the treatment of cardiovascular and cardio-metabolic diseases and disorders, namely, hypertension, heart failure, dyslipidemia, thrombosis and diabetes; pharmaceutical preparations for the treatment of urological disorders and diseases; pharmaceutical preparations for the treatment of allergies; pharmaceutical preparations, namely, anti-histamines; allergen extracts for allergen immunotherapy and for diagnostic allergy testing; pharmaceutical preparations for the treatment of respiratory diseases and disorders, namely, asthma, chronic obstructive pulmonary disease, allergic rhinitis and cough; pharmaceutical preparations for the treatment of infectious diseases, namely, bacterial, viral, fungal and parasitic infections; pharmaceutical preparations for the treatment of musculoskeletal diseases and disorders, namely, osteoarthritis, rheumatoid arthritis, osteoporosis and inflammation; pharmaceutical preparations for the treatment of gout; pharmaceutical preparations for use in women's health, obstetrics, gynecology and maternity care, namely, preparations for labor induction, postpartum hemorrhage, contraception and menopause; pharmaceutical preparations for the treatment of iron deficiency and anemia; medical preparations for use in the diagnosis of diseases and disorders of the central and peripheral nervous system; sanitary preparations for medical purposes; dietetic food and dietic preparations adapted for medical use, namely, nutritionally fortified beverages for medical purposes; food for babies; dietary supplements for human beings | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, scientific research and development in the field of pharmaceuticals and biotechnology, and new pharmaceutical product design; industrial analysis, namely, chemical and biological analysis of pharmaceutical compounds and formulations; industrial research in the field of pharmaceutical preparations and drug discovery; industrial design services; quality control for others in the field of pharmaceutical products and manufacturing; authentication services in the field of pharmaceutical products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 14, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 14, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 14, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 2, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 13, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 13, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 11, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 10, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 28, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 27, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 27, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 23, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |